Quick Dosage Indications Dosages Interactions Precautions Contraindications Adverse Reactions

Interactions: Atenolol Adverse Effect: hypoglycemia, hyperglycemia, or hypertension Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided. Bisoprolol Adverse Effect: hypoglycemia, hyperglycemia, or hypertension Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided. Celiprolol Adverse Effect: hypoglycemia, hyperglycemia, or hypertension Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (Atenolol, Metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided. Chlorpropamide Adverse Effect: An increased risk of hypoglycemia Clinical Management: Monitor closely blood glucose concentrations when acarbose is added to or withdrawn from Chlorpropamide. Doses of either or both drugs may need to be adjusted to minimize hypoglycemic effects. Digoxin Adverse Effect: decreased digoxin efficacy Clinical Management: Patients receiving digoxin and acarbose therapy should be instructed to take their medications consistently at the same time interval daily to avoid any fluctuations in their digoxin levels. Glibenclamide Adverse Effect: An increased risk of hypoglycemia Clinical Management: Monitor closely blood glucose concentrations when acarbose is added to or withdrawn from Glibenclamide . Doses of either or both drugs may need to be adjusted to minimize hypoglycemic effects. Patients receiving these medications should be counselled to carry a supply of glucose tablets. Gliclazide Adverse Effect: An increased risk of hypoglycemia Clinical Management: Monitor closely blood glucose concentrations when acarbose is added to or withdrawn from Gliclazide . Dose of either or both drugs may need to be adjusted to minimize hypoglycemic effects. Patients receiving these medications should be counselled to carry a supply of glucose tablets. Glipizide Adverse Effect: An increased risk of hypoglycemia Clinical Management: Monitor closely blood glucose concentrations when acarbose is added to or withdrawn from Glipizide . Dose of either or both drugs may need to be adjusted to minimize hypoglycemic effects. Patients receiving these medications should be counselled to carry a supply of glucose tablets. Insulin Lispro Adverse Effect: increased risk of hypoglycemia Clinical Management: Monitor closely blood glucose concentrations when acarbose is added to or withdrawn from therapy. Doses of either or both acarbose and insulin may need to be adjusted to minimize hypoglycemic effects. Patients receiving these medications should be counselled to carry a supply of glucose tablets. Insulins - Lente / Zn Adverse Effect: Increased risk of hypoglycemia Clinical Management: Monitor closely blood glucose concentrations when acarbose is added to or withdrawn from therapy. Doses of either or both acarbose and insulin may need to be adjusted to minimize hypoglycemic effects. Patients receiving these medications should be counselled to carry a supply of glucose tablets or glucose liquid rather than food products which may contain sucrose. Sucrose is not effective in rapidly correcting hypoglycemia in acarbose-treated patients. Acarbose inhibits the hydrolysis of sucrose to glucose and fructose. Insulins - NPH / Isophane Adverse Effect: Increased risk of hypoglycemia Clinical Management: Monitor closely blood glucose concentrations when acarbose is added to or withdrawn from therapy. Doses of either or both acarbose and insulin may need to be adjusted to minimize hypoglycemic effects. Patients receiving these medications should be counselled to carry a supply of glucose tablets or glucose liquid rather than food products which may contain sucrose. Sucrose is not effective in rapidly correcting hypoglycemia in acarbose-treated patients. Acarbose inhibits the hydrolysis of sucrose to glucose and fructose. Insulins - Neutral Soluble Adverse Effect: Increased risk of hypoglycemia Clinical Management: Monitor closely blood glucose concentrations when acarbose is added to or withdrawn from therapy. Doses of either or both acarbose and insulin may need to be adjusted to minimize hypoglycemic effects. Patients receiving these medications should be counselled to carry a supply of glucose tablets or glucose liquid rather than food products which may contain sucrose. Sucrose is not effective in rapidly correcting hypoglycemia in acarbose-treated patients. Acarbose inhibits the hydrolysis of sucrose to glucose and fructose. Insulins - Premixed Biphasic Adverse Effect: Increased risk of hypoglycemia Clinical Management: Monitor closely blood glucose concentrations when acarbose is added to or withdrawn from therapy. Doses of either or both acarbose and insulin may need to be adjusted to minimize hypoglycemic effects. Patients receiving these medications should be counselled to carry a supply of glucose tablets or glucose liquid rather than food products which may contain sucrose. Sucrose is not effective in rapidly correcting hypoglycemia in acarbose-treated patients. Acarbose inhibits the hydrolysis of sucrose to glucose and fructose. Metoprolol Adverse Effect: hypoglycemia, hyperglycemia, or hypertension Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided. Oxprenolol Adverse Effect: hypoglycemia, hyperglycemia, or hypertension Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided. Pindolol Adverse Effect: hypoglycemia, hyperglycemia, or hypertension Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided. Propranolol Adverse Effect: hypoglycemia, hyperglycemia, or hypertension Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided. Tolbutamide Adverse Effect: An increased risk of hypoglycemia Clinical Management: Monitor closely blood glucose concentrations when Acarbose is added to or withdrawn from Tolbutamide . Dose of either or both drugs may need to be adjusted to minimize hypoglycemic effects. Patients receiving these medications should be counselled to carry a supply of glucose tablets. Warfarin Adverse Effect: An increased risk of bleeding Clinical Management: Closely monitor the international normalized ratio (INR) following initiation or discontinuation of acarbose therapy in patients previously stabilized on warfarin.

Acetaminophen Adenosine AlbuterolSulfate Allopurinol Alprostadil AmantadineHydrochloride AmikacinSulfate Aminophylline Amoxicillin AmoxicillinTrihydrate Amphotericin B Amphotericin B Cholesteryl Sulfate Complex Ampicillin Ampicillin Sodium Ascorbic Acid (Vitamin C) Aspirin Atropine Sulfate Azelastine Hydrochloride Aztreonam Abciximab Acenocoumarol Acarbose Acetazolamide Acetazolamide - Ocular Acyclovir Acyclovir - Ocular Acyclovir-AV Adapalene Adrenaline Adrenaline - Inh Adrenaline - resp Adrenochrome Albendazole Aldosterone Alendronate Alprazolam Amantadine-AV Amifostine Amikacin Amiloride Aminocaproic Acid Amiodarone Amitriptyline Amlodipine Amodiaquine Amoxapine Amrinone Analgin Aprotinin Ardeparin Arteether Artemether Artesunate Aspartame Astemizole Atenolol Atorvastatin Atracurium Auranofin ( Gold ) Azatadine Azathioprine Azithromycin